3

MAIN DOCUMENT DESCRIPTION

Company: Jazz Pharmaceuticals plc
Filed: January 18, 2012
Period of Report: January 18, 2012
Accession Number: 0001209191-12-004341

View Document ↗ View on SEC.gov ↗